Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vascular Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 312 articles:
HTML format
Text format



Single Articles


    October 2018
  1. FABRIS E, Van't Hof A, Hamm CW, Lapostolle F, et al
    Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.
    Catheter Cardiovasc Interv. 2018 Oct 9. doi: 10.1002/ccd.27921.
    PubMed     Text format     Abstract available


    April 2018
  2. SETO AH, Kern MJ
    Early stent thrombosis: Nearly gone, but never forgotten.
    Catheter Cardiovasc Interv. 2018;91:849-850.
    PubMed     Text format     Abstract available


  3. KHAN AA, Dangas GD
    The quest for a "diabetic" stent.
    Catheter Cardiovasc Interv. 2018;91:892-893.
    PubMed     Text format     Abstract available


    March 2018
  4. XIE R, Hillegass WB
    Long-term survival prospects of patients undergoing percutaneous coronary intervention: Envisioning the future.
    Catheter Cardiovasc Interv. 2018;91:696.
    PubMed     Text format     Abstract available


  5. SAFIAN RD
    Carotid stenting with double layered stents: Double trouble or double benefit?
    Catheter Cardiovasc Interv. 2018;91:758-759.
    PubMed     Text format     Abstract available


  6. CHAMBERS CE, Koduri HK
    Real time patient dosimetry in the cath lab: Can you see what they get?
    Catheter Cardiovasc Interv. 2018;91:723-724.
    PubMed     Text format     Abstract available


  7. GOMES JUNIOR MPM, Alves CMR, Barbosa AHP, Caixeta A, et al
    Initial experience with the use of fractional flow reserve in the hemodynamic evaluation of transplant renal artery stenosis.
    Catheter Cardiovasc Interv. 2018;91:820-826.
    PubMed     Text format     Abstract available


  8. TAJTI P, Karmpaliotis D, Alaswad K, Toma C, et al
    Prevalence, Presentation and Treatment of 'Balloon Undilatable' Chronic Total Occlusions: Insights from a Multicenter US Registry.
    Catheter Cardiovasc Interv. 2018;91:657-666.
    PubMed     Text format     Abstract available


  9. SANNINO A, Giugliano G, Toscano E, Schiattarella GG, et al
    Double layered stents for carotid angioplasty: A meta-analysis of available clinical data.
    Catheter Cardiovasc Interv. 2018;91:751-757.
    PubMed     Text format     Abstract available


  10. YEH CF, Chen YH, Lin MS, Huang CC, et al
    Carotid-cavernous fistula after endovascular intervention for chronic carotid artery total occlusion.
    Catheter Cardiovasc Interv. 2018;91:735-741.
    PubMed     Text format     Abstract available


  11. REEVES RR, Walters D, Mahmud E
    Renal artery stenosis and ambulatory blood pressure monitoring: A case report and review of the literature.
    Catheter Cardiovasc Interv. 2018;91:760-764.
    PubMed     Text format     Abstract available


  12. WON KB, Yoon HJ, Lee SG, Cho YK, et al
    Comparison of long-term mortality according to obesity in patients with successful percutaneous chronic total occlusion interventions using drug-eluting stents.
    Catheter Cardiovasc Interv. 2018;91:710-716.
    PubMed     Text format     Abstract available


  13. TAKAGI H, Ando T, Umemoto T
    Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease.
    Catheter Cardiovasc Interv. 2018;91:697-709.
    PubMed     Text format     Abstract available


  14. GEBHARD C, Gick M, Ferenc M, Stahli BE, et al
    Coronary dominance and prognosis in patients with chronic total occlusion treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018;91:669-678.
    PubMed     Text format     Abstract available


  15. LI C, Xu R, Shen Y, Dai Y, et al
    Bivalirudin in percutaneous coronary intervention for chronic total occlusion: A single-center pilot study.
    Catheter Cardiovasc Interv. 2018;91:679-685.
    PubMed     Text format     Abstract available


  16. VAN BOVEN N, van Domburg RT, Kardys I, Umans VA, et al
    Development and validation of a risk model for long-term mortality after percutaneous coronary intervention: The IDEA-BIO Study.
    Catheter Cardiovasc Interv. 2018;91:686-695.
    PubMed     Text format     Abstract available


  17. ICHIMOTO E, Kadohira T, Nakayama T, De Gregorio J, et al
    Efficacy of radiation dose reduction due to real-time monitoring and visualization of peak skin dose during coronary angiography and percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018;91:717-722.
    PubMed     Text format     Abstract available


  18. AZZALINI L, Carlino M, Brilakis ES, Vo M, et al
    Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of "vessel architecture".
    Catheter Cardiovasc Interv. 2018;91:725-734.
    PubMed     Text format     Abstract available


    February 2018
  19. SINHA S, Levi D, Peirone A, Pedra C, et al
    Techniques for trans-catheter retrieval of embolized Nit-Occlud((R)) PDA-R and ASD-R devices.
    Catheter Cardiovasc Interv. 2018;91:478-484.
    PubMed     Text format     Abstract available


  20. SCHROE H, Holden AH, Goueffic Y, Jansen SJ, et al
    Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.
    Catheter Cardiovasc Interv. 2018;91:497-504.
    PubMed     Text format     Abstract available


  21. CAPRANZANO P, Capodanno D, Brugaletta S, Latib A, et al
    Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry.
    Catheter Cardiovasc Interv. 2018;91:444-453.
    PubMed     Text format     Abstract available


  22. DOHAD S, Zhu A, Krishnan S, Wang F, et al
    Optical coherence tomography guided carotid artery stent procedure: technique and potential applications.
    Catheter Cardiovasc Interv. 2018;91:521-530.
    PubMed     Text format     Abstract available


  23. GASPARINI GL, Oreglia JA, Reimers B
    Self-apposing stent-assisted coil embolization for the treatment of coronary artery aneurysm.
    Catheter Cardiovasc Interv. 2018;91:470-474.
    PubMed     Text format     Abstract available


  24. JANAS A, Milewski K, Buszman PP, Janas K, et al
    Safety and feasibility of same-day early discharge after endovascular revascularization of lower extremities in elderly. SENIOR-ER registry.
    Catheter Cardiovasc Interv. 2018;91:515-520.
    PubMed     Text format     Abstract available


  25. KOBAYASHI N, Hirano K, Yamawaki M, Araki M, et al
    Characteristics and clinical outcomes of repeat endovascular therapy after infrapopliteal balloon angioplasty in patients with critical limb ischemia.
    Catheter Cardiovasc Interv. 2018;91:505-514.
    PubMed     Text format     Abstract available


  26. PURI R, Otaegui I, Sabate M, Serra-Penaranda A, et al
    Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite(R) drug-eluting stent: The ANCHOR study.
    Catheter Cardiovasc Interv. 2018;91:435-443.
    PubMed     Text format     Abstract available


  27. WALDO SW, O'Donnell CI, Prouse A, Plomondon ME, et al
    Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program.
    Catheter Cardiovasc Interv. 2018;91:425-433.
    PubMed     Text format     Abstract available


  28. SETHI A, Singbal Y, Rastogi U, Prasad VS, et al
    Late Incomplete stent apposition is associated with late/very late stent thrombosis: A meta-analysis.
    Catheter Cardiovasc Interv. 2018;91:365-375.
    PubMed     Text format     Abstract available


  29. QIAN F, Zhong Y, Hannan EL
    Four-year comparative effectiveness of bare-metal and everolimus-eluting stents in New York.
    Catheter Cardiovasc Interv. 2018;91:417-424.
    PubMed     Text format     Abstract available


  30. ROZEMEIJER R, Stein M, Frambach P, Voskuil M, et al
    Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.
    Catheter Cardiovasc Interv. 2018;91:410-416.
    PubMed     Text format     Abstract available


  31. ADJEDJ J, Toth GG, Pellicano M, Wijns W, et al
    Reversed single string technique for coronary bifurcation stenting-First report of case demonstrations in vitro.
    Catheter Cardiovasc Interv. 2018;91:396-401.
    PubMed     Text format     Abstract available


  32. KLEIN-WIELE O, Baliota M, Kara K, Kaunicke M, et al
    Safety and efficacy of clip-based vs. suture mediated vascular closure for femoral access hemostasis: A prospective randomized single center study comparing the StarClose and the ProGlide device.
    Catheter Cardiovasc Interv. 2018;91:402-407.
    PubMed     Text format     Abstract available


  33. VAN BOMMEL RJ, Lemmert ME, van Mieghem NM, van Geuns RJ, et al
    Occurrence and predictors of acute stent recoil-A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent.
    Catheter Cardiovasc Interv. 2018;91:E21-E28.
    PubMed     Text format     Abstract available


  34. CAMPOS CM, Caixeta A, Franken M, Bartorelli AL, et al
    Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND an
    Catheter Cardiovasc Interv. 2018;91:387-395.
    PubMed     Text format     Abstract available


  35. GASIOR P, Cheng Y, Estrada EA, Jenn McGregor, et al
    Novel ultrahigh molecular weight amorphous PLLA bioresorbable coronary scaffold upsized up to 0.8 mm beyond nominal diameter: An OCT and histopathology study in porcine coronary artery model.
    Catheter Cardiovasc Interv. 2018;91:378-386.
    PubMed     Text format     Abstract available


  36. GAO G, Feng L, Zhang D, Song C, et al
    Proximal left anterior descending coronary artery stenosis should be considered when using the prognostic value of the residual SYNTAX score: Data from 10343 consecutive patients with long-term follow up in the real world.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  37. CHE W, Xiong H, Jiang X, Dong H, et al
    Stenting for middle aortic syndrome caused by Takayasu arteritis-immediate and long-term outcomes.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  38. ZHAO Z, Zhang D, Xu B, Wang H, et al
    Is side branch lesion length an independent predictor of acute side branch occlusion in provisional strategy? Analysis of 524 consecutive bifurcation lesions.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  39. HE Y, Zhang D, Yin D, Zhu C, et al
    Validation of the V-RESOLVE (Visual Estimation for Risk prEdiction of Side Branch OccLusion in Coronary Bifurcation interVEntion) score system.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  40. XU JJ, Gao Z, Zhang Y, Gao LJ, et al
    Dual antiplatelet therapy after coronary drug-eluting stent implantation in China: A large single center study.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  41. SONG L, Li J, Guan C, Jing Q, et al
    Randomized comparison of novel biodegradable polymer and durable polymer-coated cobalt-chromium sirolimus-eluting stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  42. SONG L, Guan C, Yan H, Qiao S, et al
    Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  43. WANG XZ, Zhang YJ, Fu GS, Jing QM, et al
    One-year clinical outcomes and multislice computed tomography angiographic results following implantation of the NeoVas bioresorbable sirolimus-eluting scaffold in patients with single de novo coronary artery lesions.
    Catheter Cardiovasc Interv. 2018 Feb 2. doi: 10.1002/ccd.27491.
    PubMed     Text format     Abstract available


  44. CHATTERJEE A, Hillegass WB
    The promise of effective P2Y12 platelet receptor pretreatment: Not crushed yet.
    Catheter Cardiovasc Interv. 2018;91:251-252.
    PubMed     Text format     Abstract available


  45. BRILAKIS ES, Krestyaninov O
    Wanted: Expert operators for coronary chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2018;91:180-181.
    PubMed     Text format     Abstract available


  46. PLITT A, Dangas G
    Cardiac enzyme elevation after coronary revascularization.
    Catheter Cardiovasc Interv. 2018;91:224-225.
    PubMed     Text format     Abstract available


  47. BUTMAN SM
    If not now, why are you waiting?
    Catheter Cardiovasc Interv. 2018;91:265-266.
    PubMed     Text format     Abstract available


  48. MISUMIDA N, Moliterno DJ
    Hybrid coronary revascularization: Time for a new comparator?
    Catheter Cardiovasc Interv. 2018;91:213-214.
    PubMed     Text format     Abstract available


  49. SCHNEIDER HE, Gravenhorst V, Paul T, Jacobshagen C, et al
    Insufficiency of a Damus-Kaye-Stansel anastomosis in a Fontan patient: Transfemoral implantation of an Edwards Sapien 3 valve.
    Catheter Cardiovasc Interv. 2018;91:292-295.
    PubMed     Text format     Abstract available


  50. MAHMOUD AN, Saad M, Elgendy AY, Mentias A, et al
    Deferred or immediate stent implantation for primary percutaneous coronary intervention: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2018;91:260-264.
    PubMed     Text format     Abstract available


  51. JONES BM, Wazni O, Rehm SJ, Shishehbor MH, et al
    Fighting fungus with a laser and a hose: Management of a giant Candida albicans implantable cardioverter-defibrillator lead vegetation with simultaneous AngioVac aspiration and laser sheath lead extraction.
    Catheter Cardiovasc Interv. 2018;91:318-321.
    PubMed     Text format     Abstract available


  52. BUNCH F, Walker C, Kassab E, Carr J, et al
    A universal drug delivery catheter for the treatment of infrapopliteal arterial disease: Results from the multi-center first-in-human study.
    Catheter Cardiovasc Interv. 2018;91:296-301.
    PubMed     Text format     Abstract available


  53. TOKUDA T, Hirano K, Yamawaki M, Araki M, et al
    Efficacy and safety of a coagulated thrombus injection for peripheral artery perforation: The coagulated thrombus hemostasis method.
    Catheter Cardiovasc Interv. 2018;91:302-307.
    PubMed     Text format     Abstract available


  54. MCGARVEY M, Ali O, Iqbal MB, Ilsley C, et al
    A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction.
    Catheter Cardiovasc Interv. 2018;91:234-241.
    PubMed     Text format     Abstract available


  55. NDREPEPA G, Colleran R, Braun S, Xhepa E, et al
    Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018;91:215-223.
    PubMed     Text format     Abstract available


  56. ARORA S, Matsushita K, Qamar A, Stacey RB, et al
    Early versus late percutaneous revascularization in patients hospitalized with non ST-segment elevation myocardial infarction: The atherosclerosis risk in communities surveillance study.
    Catheter Cardiovasc Interv. 2018;91:253-259.
    PubMed     Text format     Abstract available


  57. SARDAR P, Kundu A, Bischoff M, Chatterjee S, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis.
    Catheter Cardiovasc Interv. 2018;91:203-212.
    PubMed     Text format     Abstract available


  58. MAEREMANS J, Spratt JC, Knaapen P, Walsh S, et al
    Towards a contemporary, comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: The RECHARGE score.
    Catheter Cardiovasc Interv. 2018;91:192-202.
    PubMed     Text format     Abstract available


  59. LIU G, Liu X, Wang R, Ye K, et al
    Catheter-Directed Thrombolysis of Acute Entire Limb Deep Vein Thrombosis From below the Knee Access: A Retrospective Analysis of a Single-Center Experience.
    Catheter Cardiovasc Interv. 2018;91:310-317.
    PubMed     Text format     Abstract available


    January 2018
  60. LIU S, Song C, Zhao Y, Zhu C, et al
    The impact of acquired thrombocytopenia on long-term outcomes of patients undergoing elective percutaneous coronary intervention: An analysis of 8,271 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Jan 25. doi: 10.1002/ccd.27498.
    PubMed     Text format     Abstract available


  61. DONG H, Che W, Jiang X, Peng M, et al
    Carotid artery stenting followed by open heart surgery in 323 patients: One-year results and influencing factors.
    Catheter Cardiovasc Interv. 2018 Jan 22. doi: 10.1002/ccd.27486.
    PubMed     Text format     Abstract available


  62. XU N, Tang XF, Yao Y, Zhao X, et al
    Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Jan 13. doi: 10.1002/ccd.27495.
    PubMed     Text format     Abstract available


  63. SHATILA W, Krajcer Z
    Chronic total occlusion: Does anti-platelet choice impact outcomes?
    Catheter Cardiovasc Interv. 2018;91:7-8.
    PubMed     Text format     Abstract available


  64. PENFORD G, Quandt D, Mehta C, Bhole V, et al
    Stenting and overdilating small Gore-Tex vascular grafts in complex congenital heart disease.
    Catheter Cardiovasc Interv. 2018;91:71-80.
    PubMed     Text format     Abstract available


  65. ARNETT DM, Lee JC, Harms MA, Kearney KE, et al
    Caliber and fitness of the axillary artery as a conduit for large-bore cardiovascular procedures.
    Catheter Cardiovasc Interv. 2018;91:150-156.
    PubMed     Text format     Abstract available


  66. VO MN, Brilakis ES, Grantham JA
    Novel use of cutting balloon to treat subintimal hematomas during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2018;91:53-56.
    PubMed     Text format     Abstract available


  67. GASPARINI GL, Oreglia JA, Garbo R
    The trap and occlude technique for retrograde wire externalization during chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2018;91:57-63.
    PubMed     Text format     Abstract available


  68. BRUGALETTA S, Gomez-Lara J, Caballero J, Ortega-Paz L, et al
    TIcaGrEloR and Absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization (TIGER-BVS trial): Rationale and study design.
    Catheter Cardiovasc Interv. 2018;91:1-6.
    PubMed     Text format     Abstract available


  69. TARANTINI G, Mojoli M, Masiero G, Cortese B, et al
    Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).
    Catheter Cardiovasc Interv. 2018;91:E1-E16.
    PubMed     Text format     Abstract available


  70. KOK MM, Weernink MGM, von Birgelen C, Fens A, et al
    Patient preference for radial versus femoral vascular access for elective coronary procedures: The PREVAS study.
    Catheter Cardiovasc Interv. 2018;91:17-24.
    PubMed     Text format     Abstract available


  71. CORTESE B, Rigattieri S, Aranzulla TC, Russo F, et al
    Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club.
    Catheter Cardiovasc Interv. 2018;91:97-102.
    PubMed     Text format     Abstract available


  72. CAPRETTI G, Carlino M, Colombo A, Azzalini L, et al
    Rotational atherectomy in the subadventitial space to allow safe and successful chronic total occlusion recanalization: Pushing the limit further.
    Catheter Cardiovasc Interv. 2018;91:47-52.
    PubMed     Text format     Abstract available


  73. PRACON R, Bangalore S, Henzel J, Cendrowska-Demkow I, et al
    A randomized comparison of modified subcutaneous "Z"-stitch versus manual compression to achieve hemostasis after large caliber femoral venous sheath removal.
    Catheter Cardiovasc Interv. 2018;91:105-112.
    PubMed     Text format     Abstract available


  74. QIAN F, Zhong Y, Hannan EL
    Comparison of 5-year outcomes of paclitaxel-eluting and endeavor zotarolimus-eluting stents in New York.
    Catheter Cardiovasc Interv. 2018;91:9-16.
    PubMed     Text format     Abstract available


  75. MIGNATTI A, Friedmann P, Slovut DP
    Targeting the safe zone: A quality improvement project to reduce vascular access complications.
    Catheter Cardiovasc Interv. 2018;91:27-32.
    PubMed     Text format     Abstract available


    December 2017
  76. BASIR MB, Schreiber T, Dixon S, Alaswad K, et al
    Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27427.
    PubMed     Text format     Abstract available


    November 2017
  77. DANIELS DV, Banerjee S, Alaswad K, Doing AH, et al
    Safety and efficacy of the hybrid approach in coronary chronic total occlusion percutaneous coronary intervention: The Hybrid Video Registry.
    Catheter Cardiovasc Interv. 2017 Nov 29. doi: 10.1002/ccd.26501.
    PubMed     Text format     Abstract available


  78. GOLDSTEIN JA
    Peri-procedural myocardial infarction: Plaques and patients "at-risk".
    Catheter Cardiovasc Interv. 2017;90:915-916.
    PubMed     Text format     Abstract available


  79. STAHLI BE, Gebhard C, Gick M, Ferenc M, et al
    Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27412.
    PubMed     Text format     Abstract available


    October 2017
  80. ARORA S, Vaidya SR, Strassle PD, Misenheimer JA, et al
    Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27357.
    PubMed     Text format     Abstract available


  81. LIANG M, Yang S, Fu N, Lu C, et al
    Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27353.
    PubMed     Text format     Abstract available


  82. EFFRON MB, Wang TY, Fonarow GC, Henry TD, et al
    The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27145.
    PubMed     Text format     Abstract available


    September 2017
  83. AZZALINI L, Candilio L, Carlino M, Colombo A, et al
    Intracoronary snaring of the retrograde guidewire: How to overcome extreme takeoff angles in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Sep 25. doi: 10.1002/ccd.27324.
    PubMed     Text format     Abstract available


    August 2017
  84. HUCZEK Z, Zbronski K, Grodecki K, Scislo P, et al
    Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Catheter Cardiovasc Interv. 2017 Aug 26. doi: 10.1002/ccd.27251.
    PubMed     Text format     Abstract available


  85. GARCIA LA, Rocha-Singh KJ, Krishnan P, Zeller T, et al
    Angiographic classification of patterns of restenosis following femoropopliteal artery intervention: A proposed scoring system.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27198.
    PubMed     Text format     Abstract available


  86. BHARADWAJ AS, Bhatheja S, Sharma SK, Kini AS, et al
    Utility of the guideliner catheter for percutaneous coronary interventions in patients with prior transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27211.
    PubMed     Text format     Abstract available


  87. KAR S
    Transulnar cardiac catheterization and percutaneous coronary intervention: techniques, transradial comparisons, anatomical considerations, and comprehensive literature review.
    Catheter Cardiovasc Interv. 2017 Aug 2. doi: 10.1002/ccd.27220.
    PubMed     Text format     Abstract available


  88. AGRAWAL M, Hakeem A, Ahmed Z, Uretsky BF, et al
    Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2017;90:225-232.
    PubMed     Text format     Abstract available


    July 2017
  89. MANGELS DR, Giri J, Hirshfeld J, Wilensky RL, et al
    Robotic-assisted percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Jul 19. doi: 10.1002/ccd.27205.
    PubMed     Text format     Abstract available


  90. MIGLIORINI A, Valenti R, Vergara R, Grazia De Gregorio M, et al
    Angiographic and clinical outcome after crush of everolimus-eluting stent for distal unprotected left main disease.
    Catheter Cardiovasc Interv. 2017;90:72-77.
    PubMed     Text format     Abstract available


    June 2017
  91. VIEIRA DE MELO RM, Hueb W, Nomura CH, Ribeiro da Silva EE, et al
    Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
    Catheter Cardiovasc Interv. 2017 Jun 2. doi: 10.1002/ccd.27125.
    PubMed     Text format     Abstract available


  92. GARCIA LA, Rosenfield KR, Metzger CD, Zidar F, et al
    SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent.
    Catheter Cardiovasc Interv. 2017;89:1259-1267.
    PubMed     Text format     Abstract available


  93. CARR SM, Lubbe DF, Huber PR
    Percutaneous transcatheter balloon dilatation and stenting to the inflow cannula stenosis of a left ventricular assist device.
    Catheter Cardiovasc Interv. 2017;89:1219-1223.
    PubMed     Text format     Abstract available


  94. ROCHA-SINGH KJ, Beckman JA, Ansel G, Lyden SP, et al
    Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Catheter Cardiovasc Interv. 2017;89:1250-1256.
    PubMed     Text format     Abstract available


  95. HUNG CS, Yeh CF, Lin MS, Chen YH, et al
    Impact of hospital volume on long-term neurological outcome in patients undergoing carotid artery stenting.
    Catheter Cardiovasc Interv. 2017;89:1242-1249.
    PubMed     Text format     Abstract available


  96. KUO JA, Feezel AA, Putnam TN, Schutte DA, et al
    Melody valve implantation within freestyle stentless porcine aortic heterograft.
    Catheter Cardiovasc Interv. 2017;89:1224-1230.
    PubMed     Text format     Abstract available


    May 2017
  97. BRENER MI, Bush A, Miller JM, Hasan RK, et al
    Influence of radial versus femoral access site on coronary angiography and intervention outcomes: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 May 25. doi: 10.1002/ccd.27043.
    PubMed     Text format     Abstract available


  98. SARNO G, Lagerqvist B, Olivecrona G, Varenhorst C, et al
    Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27030.
    PubMed     Text format     Abstract available


  99. TARAMASSO M, Denegri A, Kuwata S, Rickli H, et al
    Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27100.
    PubMed     Text format     Abstract available


  100. VERDOIA M, Barbieri L, Parodi G, Bellandi B, et al
    Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26967.
    PubMed     Text format     Abstract available


  101. POWELL RJ, Jaff MR, Schroe H, Benko A, et al
    Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system.
    Catheter Cardiovasc Interv. 2017;89:1069-1077.
    PubMed     Text format     Abstract available


  102. FOLEY TR, Cotter RP, Kokkinidis DG, Nguyen DD, et al
    Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Catheter Cardiovasc Interv. 2017;89:1078-1085.
    PubMed     Text format     Abstract available


  103. MORIYAMA N, Tanaka Y, Saito S
    Bailout polytetrafluoroethylene-covered stent implantation for left main bifurcation perforation using the kissing stent technique.
    Catheter Cardiovasc Interv. 2017;89:1022-1027.
    PubMed     Text format     Abstract available


  104. WERNER GS, Glaser P, Coenen A, Moehlis H, et al
    Reduction of radiation exposure during complex interventions for chronic total coronary occlusions: Implementing low dose radiation protocols without affecting procedural success rates.
    Catheter Cardiovasc Interv. 2017;89:1005-1012.
    PubMed     Text format     Abstract available


  105. SHIRAI S, Hirano K, Kobayashi N
    New endovascular technique for thrombus in the non-stenting zone-the Grab a Clot and Hold ON "(GACHON) technique": Case report.
    Catheter Cardiovasc Interv. 2017;89:1087-1092.
    PubMed     Text format     Abstract available


  106. BOURAS G, Jhamnani S, Ng VG, Haimi I, et al
    Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
    Catheter Cardiovasc Interv. 2017;89:984-991.
    PubMed     Text format     Abstract available


  107. ANDRADE PB, Mattos LA, Rinaldi FS, Bienert IC, et al
    Comparison of a vascular closure device versus the radial approach to reduce access site complications in non-ST-segment elevation acute coronary syndrome patients: The angio-seal versus the radial approach in acute coronary syndrome trial.
    Catheter Cardiovasc Interv. 2017;89:976-982.
    PubMed     Text format     Abstract available


    April 2017
  108. SCHREIBER T, Wah Htun W, Blank N, Telila T, et al
    Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.26979.
    PubMed     Text format     Abstract available


  109. MALLIDI JR, Robinson P, Visintainer PF, Lotfi AS, et al
    Comparison of antithrombotic agents during urgent percutaneous coronary intervention following thrombolytic therapy: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.27042.
    PubMed     Text format     Abstract available


  110. PATEL A, Nazif T, Stone GW, Ali ZA, et al
    Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis.
    Catheter Cardiovasc Interv. 2017;89:876-879.
    PubMed     Text format     Abstract available


  111. AZZALINI L, Dautov R, Ojeda S, Serra A, et al
    Long-term outcomes of rotational atherectomy for the percutaneous treatment of chronic total occlusions.
    Catheter Cardiovasc Interv. 2017;89:820-828.
    PubMed     Text format     Abstract available


  112. PALENA LM, Diaz-Sandoval LJ, Sultato E, Brigato C, et al
    Feasibility and 1-Year outcomes of subintimal revascularization with supera(R) stenting of long femoropopliteal occlusions in critical limb ischemia: The "Supersub" Study.
    Catheter Cardiovasc Interv. 2017;89:910-920.
    PubMed     Text format     Abstract available


  113. LEE MS, Lee AC, Shlofmitz RA, Martinsen BJ, et al
    ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
    Catheter Cardiovasc Interv. 2017;89:841-848.
    PubMed     Text format     Abstract available


  114. ORTEGA-PAZ L, Capodanno D, Giacchi G, Gori T, et al
    Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.
    Catheter Cardiovasc Interv. 2017;89:812-818.
    PubMed     Text format     Abstract available


  115. HUDED CP, Youmans QR, Sweis RN, Ricciardi MJ, et al
    The impact of operator experience during institutional adoption of trans-radial cardiac catheterization.
    Catheter Cardiovasc Interv. 2017;89:860-865.
    PubMed     Text format     Abstract available


  116. SAKAKURA K, Funayama H, Taniguchi Y, Tsurumaki Y, et al
    The incidence of slow flow after rotational atherectomy of calcified coronary arteries: A randomized study of low speed versus high speed.
    Catheter Cardiovasc Interv. 2017;89:832-840.
    PubMed     Text format     Abstract available


  117. HABARA M, Tsuchikane E, Nasu K, Kinoshita Y, et al
    The first clinical experience with a novel directional coronary atherectomy catheter: Preliminary Japanese multicenter experience.
    Catheter Cardiovasc Interv. 2017;89:880-887.
    PubMed     Text format     Abstract available


  118. DAUTOV R, Nguyen CM, Rinfret S
    Stent luxation: Possible complication of subadventitial stenting in coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2017;89:872-875.
    PubMed     Text format     Abstract available


  119. SANDOVAL Y, Brilakis ES
    The role of rotational atherectomy in contemporary chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017;89:829-831.
    PubMed     Text format     Abstract available


  120. HILLEGASS WB
    The many radial access learning curves.
    Catheter Cardiovasc Interv. 2017;89:865-866.
    PubMed     Text format     Abstract available


  121. BELARDI JA, Albertal M
    Overlapping bioresorbable scaffolds seems safe for now.
    Catheter Cardiovasc Interv. 2017;89:818-819.
    PubMed     Text format     Abstract available


  122. ANSEL GM, Jaff MR
    The Italian stallions of CLI "value care" delivery.
    Catheter Cardiovasc Interv. 2017;89:921-922.
    PubMed     Text format     Abstract available


    March 2017
  123. DIN JN, Snow TM, Rao SV, Klinke WP, et al
    Variation in practice and concordance with guideline criteria for length of stay after elective percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 31. doi: 10.1002/ccd.26992.
    PubMed     Text format     Abstract available


  124. MINA GS, Firouzbakht T, Modi K, Dominic P, et al
    Gender-based outcomes of bivalirudin versus heparin in patients undergoing percutaneous coronary interventions: Meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2017 Mar 24. doi: 10.1002/ccd.26985.
    PubMed     Text format     Abstract available


  125. VISHNEVSKY A, Julien HM, Fischman DL, Walinsky P, et al
    Unrecognized coronary vasospasm in patients referred for percutaneous coronary intervention: Intracoronary nitroglycerin, the forgotten stepchild of cardiovascular guidelines.
    Catheter Cardiovasc Interv. 2017 Mar 20. doi: 10.1002/ccd.27034.
    PubMed     Text format     Abstract available


  126. SOLA M, Venkatesh K, Caughey M, Rayson R, et al
    Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26963.
    PubMed     Text format     Abstract available


  127. KARIMI GALOUGAHI K, Mintz GS, Karmpaliotis D, Ali ZA, et al
    Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26999.
    PubMed     Text format     Abstract available


  128. SUKUL D, Seth M, Schreiber T, Khandelwal A, et al
    The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27001.
    PubMed     Text format     Abstract available


  129. MAHMOUD AN, Elgendy IY, Mentias A, Saad M, et al
    Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26970.
    PubMed     Text format     Abstract available


  130. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
    Role of residual acute stent malapposition in percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26974.
    PubMed     Text format     Abstract available


  131. WILSON WM, Walsh SJ, Bagnall A, Yan AT, et al
    One-year outcomes after successful chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26980.
    PubMed     Text format     Abstract available


  132. DEUSCHL F, Schofer N, Seiffert M, Hakmi S, et al
    Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26986.
    PubMed     Text format     Abstract available


  133. MENTIAS A, Mahmoud AN, Elgendy IY, Elgendy AY, et al
    Ischemic postconditioning during primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26965.
    PubMed     Text format     Abstract available


  134. SHARMA D, Kotowycz MA, Sharma V, Choudhury A, et al
    Characteristics and outcomes of patients undergoing percutaneous coronary intervention within 1 year of coronary artery bypass graft surgery.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26853.
    PubMed     Text format     Abstract available


  135. CHE W, Dong H, Jiang X, Peng M, et al
    Subclavian artery stenting for coronary-subclavian steal syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  136. JIA H, Hu S, Liu H, Zhu Y, et al
    Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  137. QI J, Li Y, Li J, Jing Q, et al
    Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  138. HU S, Wang C, Zhe C, Zhu Y, et al
    Plaque erosion delays vascular healing after drug eluting stent implantation in patients with acute coronary syndrome: An In Vivo Optical Coherence Tomography Study.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  139. HE C, Ma YL, Wang CS, Song Y, et al
    Effect of coronary dominance on 2-year outcomes after percutaneous coronary intervention in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  140. GAO L, Wang Y, Liu Y, Cao F, et al
    Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  141. QIU M, Li Y, Li J, Xu K, et al
    Impact of six versus 12 months of dual antiplatelet therapy in patients with drug-eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  142. DONG H, Peng M, Jiang X, Che W, et al
    Endovascular therapy for Angio-sealTM -related acute limb ischemia: Perioperative and long-term results.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  143. WANG G, Wang H, Xu B, Yang Y, et al
    Efficacy and safety of a biodegradable polymer Cobalt-Chromium sirolimus-eluting stent (EXCEL2) in treating de novo coronary artery disease: A pooled analysis of the CREDIT II and CREDIT III trials.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  144. XU B, Bettinger N, Guan C, Redfors B, et al
    Impact of completeness of revascularization in complex coronary artery disease as measured with the SYNTAX revascularization index: An SEEDS Substudy.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  145. BLOOMER TL, El-Hayek GE, McDaniel MC, Sandvall BC, et al
    Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: Results of a multicenter registry and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89:754-760.
    PubMed     Text format     Abstract available


  146. LATINI RA, Buccheri D, Cortese B
    First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Catheter Cardiovasc Interv. 2017;89:676-678.
    PubMed     Text format     Abstract available


  147. BELARDI JA, Albertal M
    Non-cardiac surgery after PCI: Watch out for complex lesions.
    Catheter Cardiovasc Interv. 2017;89:627-628.
    PubMed     Text format    


  148. AZZALINI L, Brilakis ES
    Ipsilateral vs. contralateral vs. no collateral (antegrade only) chronic total occlusion percutaneous coronary interventions: What is the right choice for your practice?
    Catheter Cardiovasc Interv. 2017;89:656-657.
    PubMed     Text format    


  149. PALMERINI T
    Myocardial revascularization with percutaneous coronary intervention: To complete or not to complete?
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format    


    February 2017
  150. COOLS B, Rega F, Gewillig M
    Transhepatic implant of a trimmed Melody valved stent in tricuspid position in a 1-year-old infant.
    Catheter Cardiovasc Interv. 2017;89:E84-E89.
    PubMed     Text format     Abstract available


  151. BABUNASHVILI AM, Pancholy SB, Kartashov DS
    New technique for treatment of postcatheterization radial artery pseudoaneurysm.
    Catheter Cardiovasc Interv. 2017;89:393-398.
    PubMed     Text format     Abstract available


  152. ORTIZ D, Singh M, Jahangir A, Allaqaband S, et al
    Bivalirudin versus unfractionated heparin during peripheral vascular interventions: A Propensity-matched Study.
    Catheter Cardiovasc Interv. 2017;89:408-413.
    PubMed     Text format     Abstract available


  153. BUTERA G, Piazza L, Heles M
    PFO "angioplasty": The preparation of a very stiff and long tunnel for device closure.
    Catheter Cardiovasc Interv. 2017;89:480-483.
    PubMed     Text format     Abstract available


  154. HEE L, Terluk A, Thomas L, Hopkins A, et al
    Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.
    Catheter Cardiovasc Interv. 2017;89:375-382.
    PubMed     Text format     Abstract available


  155. ZAHR F, Cigarroa JE
    Revascularization after coronary artery bypass grafting; Another episode in a long saga.
    Catheter Cardiovasc Interv. 2017;89:349-350.
    PubMed     Text format    


  156. AZZALINI L, Jolicoeur EM
    The wise radialist's guide to optimal transfemoral access: Selection, performance, and troubleshooting.
    Catheter Cardiovasc Interv. 2017;89:399-407.
    PubMed     Text format     Abstract available


  157. ZHANG D, Li Y, Yin D, He Y, et al
    Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: Analysis based on the SCAI definition.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26939.
    PubMed     Text format     Abstract available


  158. LUZ A, Silveira I, Brochado B, Rodrigues P, et al
    Manual thrombectomy efficiency in relationship to the area at risk in patients with myocardial infarction with TIMI 0-1 coronary flow: Insights from an all comers registry.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26959.
    PubMed     Text format     Abstract available


  159. SOUZA CF, Maehara A, Mintz GS, Matsumura M, et al
    Tissue characterization and phenotype classification in patients presenting with acute myocardial infarction: Insights from the iWonder study.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26954.
    PubMed     Text format     Abstract available


  160. RAVAT H, Garekar S, Changela V
    Left main coronary angioplasty of a 9-year-old child with bioresorable vascular scaffold.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26896.
    PubMed     Text format     Abstract available


  161. DEHARO P, Strange JW, Mozid A
    Primary percutaneous coronary intervention of native chronic total occlusions to treat ST elevation myocardial infarction secondary to acute vein graft occlusion.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26905.
    PubMed     Text format     Abstract available


  162. CZARNY MJ, Hwang CW, Naiman DQ, Lemmon CC, et al
    Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.
    Catheter Cardiovasc Interv. 2017 Feb 4. doi: 10.1002/ccd.26953.
    PubMed     Text format     Abstract available


  163. POTERUCHA JT, Taggart NW, Johnson JN, Cannon BC, et al
    Intravascular and hybrid intraoperative stent placement for baffle obstruction in transposition of the great arteries after atrial switch.
    Catheter Cardiovasc Interv. 2017;89:306-314.
    PubMed     Text format     Abstract available


  164. KLEIN LW, Harjai KJ, Resnic F, Weintraub WS, et al
    2016 Revision of the SCAI position statement on public reporting.
    Catheter Cardiovasc Interv. 2017;89:269-279.
    PubMed     Text format    


  165. VAN DEN HOVEN AT, Duijnhouwer AL, Eicken A, Aboulhosn J, et al
    Adverse outcome of coarctation stenting in patients with Turner syndrome.
    Catheter Cardiovasc Interv. 2017;89:280-287.
    PubMed     Text format     Abstract available


  166. LIGON RA, Petit CJ
    Not that atretic: Use of an atretic femoral vein for transcatheter pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2017;89:321-323.
    PubMed     Text format     Abstract available


  167. GARBO R, Oreglia JA, Gasparini GL
    The Balloon-Microcatheter technique for treatment of coronary artery perforations.
    Catheter Cardiovasc Interv. 2017;89:E75-E83.
    PubMed     Text format     Abstract available


  168. SHAH AH, Horlick EM, Eicken A, Asnes JD, et al
    Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Bjork-fontan procedure.
    Catheter Cardiovasc Interv. 2017;89:298-305.
    PubMed     Text format     Abstract available


  169. SAWAYA FJ, Morice MC, Spaziano M, Mehran R, et al
    Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials.
    Catheter Cardiovasc Interv. 2017;89:178-189.
    PubMed     Text format     Abstract available


  170. SHEMISA K, Karatasakis A, Brilakis ES
    Management of guidewire-induced distal coronary perforation using autologous fat particles versus coil embolization.
    Catheter Cardiovasc Interv. 2017;89:253-258.
    PubMed     Text format     Abstract available


  171. PARSH J, Seth M, Green J, Sutton NR, et al
    Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26917.
    PubMed     Text format     Abstract available


    January 2017
  172. CHATTERJEE S, Kundu A, Mukherjee D, Sardar P, et al
    Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.
    Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26928.
    PubMed     Text format     Abstract available


  173. GUAN C, Xu B, Qiao S, Qin L, et al
    Comparison of two biodegradable-polymer-based sirolimus-eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26918.
    PubMed     Text format     Abstract available


  174. TENEKECIOGLU E, Albuquerque FN, Sotomi Y, Zeng Y, et al
    Intracoronary optical coherence tomography: Clinical and research applications and intravascular imaging software overview.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26920.
    PubMed     Text format     Abstract available


  175. BROWN ED, Blankenship JC
    A mechanism for stroke complicating thrombus aspiration.
    Catheter Cardiovasc Interv. 2017;89:93-96.
    PubMed     Text format     Abstract available


  176. XHEPA E, Tada T, Kufner S, Ndrepepa G, et al
    Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials.
    Catheter Cardiovasc Interv. 2017;89:1-10.
    PubMed     Text format     Abstract available


  177. KAWAMOTO H, Takagi K, Chieffo A, Ruparelia N, et al
    Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry.
    Catheter Cardiovasc Interv. 2017;89:13-24.
    PubMed     Text format     Abstract available


  178. NAGANUMA T, Colombo A, Lesiak M, Capodanno D, et al
    Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.
    Catheter Cardiovasc Interv. 2017;89:47-56.
    PubMed     Text format     Abstract available


  179. BOUDJEMLINE Y
    Covidien micro vascular plug in congenital heart diseases and vascular anomalies: A new kid on the block for premature babies and older patients.
    Catheter Cardiovasc Interv. 2017;89:114-119.
    PubMed     Text format     Abstract available


  180. FERRARO G, Marini D, Agnoletti G
    Off-label use of the amplatzer ductal occluder II additional size for percutaneous treatment of acute aortic occlusion in a baby.
    Catheter Cardiovasc Interv. 2017;89:E26-E29.
    PubMed     Text format     Abstract available


  181. BUTERA G, Lovin N, Basile DP
    How to deal with atrial septal defect closure from right internal jugular vein: Role of venous-arterial circuit for sizing and over-the-wire device implantation.
    Catheter Cardiovasc Interv. 2017;89:120-123.
    PubMed     Text format     Abstract available


  182. URIBE CE, Zuniga M, Madrid C
    Mechanical thrombectomy using the Solitaire stent in a left main coronary artery: A novel approach to coronary thrombus retrieval.
    Catheter Cardiovasc Interv. 2017;89:71-77.
    PubMed     Text format     Abstract available


  183. BELARDI JA, Albertal M
    Double-stenting in distal left main lesions: Let's crush.
    Catheter Cardiovasc Interv. 2017;89:24-25.
    PubMed     Text format     Abstract available


  184. CHATTERJEE A, Hillegass WB
    Unprotected Left Main Disease and Percutaneous Intervention: A Prototype for Precision Medicine.
    Catheter Cardiovasc Interv. 2017;89:11-12.
    PubMed     Text format     Abstract available


    December 2016
  185. NOMAN A, Balasubramaniam K, Alhous MH, Lee K, et al
    Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26882.
    PubMed     Text format     Abstract available


  186. DING L, Pockett C, Moore J, El-Said H, et al
    Long sheath use in femoral artery catheterizations in infants <15 kg is associated with a higher thrombosis rate: Proposed Protocol for Detection and Management.
    Catheter Cardiovasc Interv. 2016;88:1108-1112.
    PubMed     Text format     Abstract available


  187. KRAJCER Z, Ramaiah VG, Huetter M, Miller LE, et al
    Fast-track endovascular aortic repair: Interim report from the prospective LIFE registry.
    Catheter Cardiovasc Interv. 2016;88:1118-1123.
    PubMed     Text format     Abstract available


  188. NGUYEN-TRONG PJ, Martinez Parachini JR, Resendes E, Karatasakis A, et al
    Procedural outcomes with use of the flash ostial system in aorto-coronary ostial lesions.
    Catheter Cardiovasc Interv. 2016;88:1067-1074.
    PubMed     Text format     Abstract available


  189. BOE BA, Rectenwald JE, Bocks ML
    Severely regurgitant left ventricle to ascending aorta conduit in a failing fontan patient treated with a vascular endograft and melody transcatheter pulmonary valve via hybrid approach.
    Catheter Cardiovasc Interv. 2016;88:1113-1117.
    PubMed     Text format     Abstract available


  190. LYEN SM, Rodrigues JC, Manghat NE, Hamilton MC, et al
    Endovascular closure of thoracic aortic pseudoaneurysms: A combined device occlusion and coil embolization technique in patients unsuitable for surgery or stenting.
    Catheter Cardiovasc Interv. 2016;88:1155-1169.
    PubMed     Text format     Abstract available


  191. SEGREST JH, Hillegass WB
    Radial Access Optimization in the Nascent Post-Adoption Era.
    Catheter Cardiovasc Interv. 2016;88:1044-1045.
    PubMed     Text format     Abstract available


  192. BROWN BJ, Abbott JD
    A helping hand: GuideLiner use to facilitate stent delivery.
    Catheter Cardiovasc Interv. 2016;88:1065-1066.
    PubMed     Text format     Abstract available


    November 2016
  193. SHARKAWI MA, Filippaios A, Dani SS, Shah SP, et al
    Identifying patients for safe early hospital discharge following st elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26873.
    PubMed     Text format     Abstract available


  194. DANEK BA, Brilakis ES
    Serenity, courage, and wisdom: The keys to successful coronary calcification treatment.
    Catheter Cardiovasc Interv. 2016;88:897-898.
    PubMed     Text format    


  195. SAFIAN RD
    Provisional rotablator for calcified lesions: The Russian roulette of PCI.
    Catheter Cardiovasc Interv. 2016;88:889-890.
    PubMed     Text format    


  196. REILLY J
    You can't get there from here.
    Catheter Cardiovasc Interv. 2016;88:932-933.
    PubMed     Text format    


  197. LEESAR MA
    Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers?
    Catheter Cardiovasc Interv. 2016;88:870-871.
    PubMed     Text format    


  198. HERBERT CE, Veeram Reddy S, Welch TR, Wang J, et al
    Bench and initial preclinical results of a novel 8 mm diameter double opposed helical biodegradable stent.
    Catheter Cardiovasc Interv. 2016;88:902-911.
    PubMed     Text format     Abstract available


  199. RUZSA Z, Toth K, Nemes B, Edes IF, et al
    Transradial and transulnar access for iliac artery interventions using sheathless guiding systems: A feasibility study.
    Catheter Cardiovasc Interv. 2016;88:923-931.
    PubMed     Text format     Abstract available


  200. TANAKA A, Jabbour RJ, Kawamoto H, Mangieri A, et al
    Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.
    Catheter Cardiovasc Interv. 2016;88:865-870.
    PubMed     Text format     Abstract available


  201. TANAKA A, Latib A, Kawamoto H, Jabbour RJ, et al
    Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds.
    Catheter Cardiovasc Interv. 2016;88:854-862.
    PubMed     Text format     Abstract available


  202. TROBS M, Achenbach S, Rother J, Klinghammer L, et al
    Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.
    Catheter Cardiovasc Interv. 2016;88:872-880.
    PubMed     Text format     Abstract available


  203. IANNACCONE M, Barbero U, D'ascenzo F, Latib A, et al
    Rotational atherectomy in very long lesions: Results for the ROTATE registry.
    Catheter Cardiovasc Interv. 2016;88:E164-E172.
    PubMed     Text format     Abstract available


  204. KOIFMAN E, Gaglia MA Jr, Escarcega RO, Bernardo NL, et al
    Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26669.
    PubMed     Text format     Abstract available


  205. ASHER E, Mansour J, Wheeler A, Kendrick D, et al
    Cost awareness decreases total percutaneous coronary intervention procedural cost: The SHOPPING (Show How Options in Price for Procedures Can Be Influenced Greatly) trial.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26835.
    PubMed     Text format     Abstract available


  206. WIMMER NJ, Dufour AB, Cho K, Gagnon DR, et al
    Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26831.
    PubMed     Text format     Abstract available


  207. CHENG R, Vanichsarn C, Patel JK, Currier J, et al
    Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26830.
    PubMed     Text format     Abstract available


  208. SHAH R, Matin K, Rogers KC, Rao SV, et al
    Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26859.
    PubMed     Text format     Abstract available


  209. SAFIAN RD
    Carotid artery stenting: Avoiding the perfect storm.
    Catheter Cardiovasc Interv. 2016;88:830-831.
    PubMed     Text format    


  210. BLANKENSHIP JC
    Thrombus aspiration: Suck it up and keep looking for a niche.
    Catheter Cardiovasc Interv. 2016;88:725-726.
    PubMed     Text format    


  211. SETO AH, Kern MJ
    Does the AToMIC trial explode concerns of contrast coagulopathy?
    Catheter Cardiovasc Interv. 2016;88:738-739.
    PubMed     Text format    


  212. MCELHINNEY DB
    Hybrid transcatheter pulmonary valve replacement: Moving into the mainstream?
    Catheter Cardiovasc Interv. 2016;88:811-813.
    PubMed     Text format    


  213. FARHAN S, Mehran R
    STEMI with multivessel disease: An ongoing battle for the optimal treatment strategy.
    Catheter Cardiovasc Interv. 2016;88:707-708.
    PubMed     Text format    


  214. ECHEVERRIA A, Krajcer Z
    Long-term outcomes of the SMART stent in femoro-popliteal disease in TASC A/B lesions and TASC C/D lesions.
    Catheter Cardiovasc Interv. 2016;88:841-842.
    PubMed     Text format    


  215. BUTMAN SM
    The newly occluded ectatic vessel: Not an ecstatic time.
    Catheter Cardiovasc Interv. 2016;88:753-754.
    PubMed     Text format    


  216. SHARMA R, Henry TD
    Come one, come all...the sooner the better!
    Catheter Cardiovasc Interv. 2016;88:689-690.
    PubMed     Text format    


  217. RIZIK DG, Hermiller JB, Kereiakes DJ
    Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  218. CHAMIE D, Garcia-Garcia H, Costa RA, Onuma Y, et al
    Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  219. PERKINS LE, Kossuth MB, Fox JC, Rapoza RJ, et al
    Paving the way to a bioresorbable technology: Development of the absorb BRS program.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  220. TAMBURINO C, Capranzano P, Francaviglia B, Ina Tamburino C, et al
    Update on clinical evidence (Part II): A summary of the main post market studies.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  221. TANAKA A, Jabbour RJ, Latib A, Colombo A, et al
    Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  222. ABIZAID A, Ribamar Costa J Jr
    The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  223. BADINGS EA, Remkes WS, The SH, Dambrink JE, et al
    Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial.
    Catheter Cardiovasc Interv. 2016;88:755-764.
    PubMed     Text format     Abstract available


  224. SOSNOWSKI C, Matella T, Fogg L, Ilbawi M, et al
    Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: Comparison with surgical PVR.
    Catheter Cardiovasc Interv. 2016;88:804-810.
    PubMed     Text format     Abstract available


  225. MATSUMI J, Tobita K, Shishido K, Mizuno S, et al
    Long-term outcomes of SMART stent implantation in patients with femoro-popliteal disease.
    Catheter Cardiovasc Interv. 2016;88:832-841.
    PubMed     Text format     Abstract available


  226. MELLER SM, Salim Al-Damluji M, Gutierrez A, Stilp E, et al
    Carotid stenting versus endarterectomy for the treatment of carotid artery stenosis: Contemporary results from a large single center study.
    Catheter Cardiovasc Interv. 2016;88:822-830.
    PubMed     Text format     Abstract available


  227. THEODOROPOULOS K, Mennuni MG, Dangas GD, Meelu OA, et al
    Resistant in-stent restenosis in the drug eluting stent era.
    Catheter Cardiovasc Interv. 2016;88:777-785.
    PubMed     Text format     Abstract available


    October 2016
  228. KODAMA A, Yamamoto M, Shimura T, Kagase A, et al
    Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Catheter Cardiovasc Interv. 2016 Oct 27. doi: 10.1002/ccd.26686.
    PubMed     Text format     Abstract available


  229. IELASI A, Varricchio A, Campo G, Leoncini M, et al
    A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study.
    Catheter Cardiovasc Interv. 2016 Oct 24. doi: 10.1002/ccd.26801.
    PubMed     Text format     Abstract available


  230. EFTYCHIOU C, Barmby DS, Wilson SJ, Ubaid S, et al
    Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience.
    Catheter Cardiovasc Interv. 2016;88:546-553.
    PubMed     Text format     Abstract available


  231. YETGIN T, van Kranenburg M, Ten Cate T, Duncker DJ, et al
    Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial.
    Catheter Cardiovasc Interv. 2016;88:508-514.
    PubMed     Text format     Abstract available


  232. ARORA S, Panaich SS, Patel N, Patel NJ, et al
    Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006-2011).
    Catheter Cardiovasc Interv. 2016;88:605-616.
    PubMed     Text format     Abstract available


  233. BASAVARAJAIAH S, Naganuma T, Latib A, Sticchi A, et al
    Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Catheter Cardiovasc Interv. 2016;88:522-528.
    PubMed     Text format     Abstract available


  234. TIAN W, Mahmoudi M, Lhermusier T, Kiramijyan S, et al
    The influence of advancing age on implantation of drug-eluting stents.
    Catheter Cardiovasc Interv. 2016;88:516-521.
    PubMed     Text format     Abstract available


  235. SINGH S, Singh N, Gulati GS, Ramakrishnan S, et al
    Dual-Source Computed Tomography for Chronic Total Occlusion of Coronary Arteries.
    Catheter Cardiovasc Interv. 2016;88:E117-E125.
    PubMed     Text format     Abstract available


  236. BELARDI JA, Albertal M
    Ischemic Postconditioning: Not Giving Up Yet.
    Catheter Cardiovasc Interv. 2016;88:514-515.
    PubMed     Text format     Abstract available


  237. SAFIAN RD
    The Third Rail of Interventional Cardiology: Revascularization of Non-Infarct-Related Arteries During Primary PCI.
    Catheter Cardiovasc Interv. 2016;88:506-507.
    PubMed     Text format    


  238. HEUSER RR
    ACS Treatment Continues to Improve: But Price Matters.
    Catheter Cardiovasc Interv. 2016;88:544-545.
    PubMed     Text format     Abstract available


    September 2016
  239. WANG H, Li Y, Cong H, Ding S, et al
    Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
    Catheter Cardiovasc Interv. 2016 Sep 28. doi: 10.1002/ccd.26804.
    PubMed     Text format     Abstract available


  240. VERMA S, Burkhoff D, O'Neill WW
    Avoiding hemodynamic collapse during high-risk percutaneous coronary intervention: Advanced hemodynamics of impella support.
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26795.
    PubMed     Text format     Abstract available


  241. CHANDRASEKHAR J, Bansilal S, Baber U, Sartori S, et al
    Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26716.
    PubMed     Text format     Abstract available


  242. SUKUL D, Seth M, Dixon SR, Zainea M, et al
    Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26781.
    PubMed     Text format     Abstract available


  243. A MCCROSSAN B, O'Callaghan B, P Walsh K
    Stent implantation to relieve native obstructed left partial anomalous pulmonary venous connections.
    Catheter Cardiovasc Interv. 2016;88:452-5.
    PubMed     Text format     Abstract available


  244. DILETTI R, Tchetche D, Barbato E, Latib A, et al
    Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.
    Catheter Cardiovasc Interv. 2016;88:397-406.
    PubMed     Text format     Abstract available


  245. GENEREUX P, Bettinger N, Redfors B, Lee AC, et al
    Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
    Catheter Cardiovasc Interv. 2016;88:369-77.
    PubMed     Text format     Abstract available


  246. MALEKZADEH-MILANI S, Jalal Z, Tamisier D, Boudjemline Y, et al
    Dilatable pulmonary artery band: Safety and efficacy of balloon dilatation.
    Catheter Cardiovasc Interv. 2016;88:446-51.
    PubMed     Text format     Abstract available


  247. SOTOMI Y, Serruys PW
    Promising, but still a matter of debate.
    Catheter Cardiovasc Interv. 2016;88:378-9.
    PubMed     Text format     Abstract available


  248. BELARDI JA, Albertal M
    To achieve, or not to achieve complete revascularization.
    Catheter Cardiovasc Interv. 2016;88:338-9.
    PubMed     Text format     Abstract available


  249. GOLDSTEIN JA
    Stenting precision: "Image small, miss small".
    Catheter Cardiovasc Interv. 2016;88:348-9.
    PubMed     Text format     Abstract available


  250. HEUSER RR
    Coronary perforation: The solution is right on the table.
    Catheter Cardiovasc Interv. 2016;88:494.
    PubMed     Text format    


  251. GEORGE S, Cotton J, Wrigley B
    Rebuttal: Coronary perforation: The solution is right on the table.
    Catheter Cardiovasc Interv. 2016;88:495.
    PubMed     Text format    


    August 2016
  252. KORABATHINA R, Levine JC, Coppola JT
    Innovative use of a guideliner catheter to assist in snare retrieval of an entrapped kinked guide catheter during transradial coronary intervention.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26774.
    PubMed     Text format     Abstract available


  253. AMINIAN A, Iglesias JF, Van Mieghem C, Zuffi A, et al
    First prospective multicenter experience with the 7 French Glidesheath slender for complex transradial coronary interventions.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26773.
    PubMed     Text format     Abstract available


  254. SETO AH, Tyler J, Suh WM, Harrison AT, et al
    Defining the common femoral artery: Insights from the femoral arterial access with ultrasound trial.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26727.
    PubMed     Text format     Abstract available


  255. PYXARAS SA, Toth GG, Di Gioia G, Ughi GJ, et al
    Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26777.
    PubMed     Text format     Abstract available


  256. MOTTILLO S, Filion KB, Joseph L, Eisenberg MJ, et al
    Defining optimal activated clotting time for percutaneous coronary intervention: A systematic review and Bayesian meta-regression.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26652.
    PubMed     Text format     Abstract available


  257. KAWAMOTO H, Ruparelia N, Latib A, Miyazaki T, et al
    Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26725.
    PubMed     Text format     Abstract available


  258. ALEXANDER J, Yohannan T, Abutineh I, Agrawal V, et al
    Ultrasound-guided femoral arterial access in pediatric cardiac catheterizations: A prospective evaluation of the prevalence, risk factors, and mechanism for acute loss of arterial pulse.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26702.
    PubMed     Text format     Abstract available


  259. YANG X, Tamez H, Lai C, Ho K, et al
    Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26688.
    PubMed     Text format     Abstract available


  260. DANEK BA, Karatasakis A, Alame AJ, Nguyen-Trong PJ, et al
    Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26696.
    PubMed     Text format     Abstract available


  261. FERKO N, Ferrante G, Hasegawa JT, Schikorr T, et al
    Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26700.
    PubMed     Text format     Abstract available


  262. RHEUDE TA, Xhepa E, Byrne RA
    Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis.
    Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26694.
    PubMed     Text format     Abstract available


  263. MIKI K, Fujii K, Kawasaki D, Shibuya M, et al
    Impact of analysis interval size on the quality of optical frequency domain imaging assessments of stent implantation for lesions of the superficial femoral artery.
    Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26673.
    PubMed     Text format     Abstract available


  264. MINGES KE, Herrin J, Fiorilli PN, Curtis JP, et al
    Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients.
    Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26701.
    PubMed     Text format     Abstract available


  265. BRADLEY EA, Berman D, Daniels CJ
    First implantable hemodynamic monitoring device placement in single ventricle fontan anatomy.
    Catheter Cardiovasc Interv. 2016;88:248-52.
    PubMed     Text format     Abstract available


  266. NOONAN P, Kudumula V, Anderson B, Ramchandani B, et al
    Stenting of the left pulmonary artery after palliation of hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2016;88:225-32.
    PubMed     Text format     Abstract available


  267. VOGEL B, Mehran R
    Arterial hypertension: A neglected risk for bleeding.
    Catheter Cardiovasc Interv. 2016;88:191-2.
    PubMed     Text format     Abstract available


  268. BELARDI JA, Albertal M
    Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues....
    Catheter Cardiovasc Interv. 2016;88:182-3.
    PubMed     Text format     Abstract available


    July 2016
  269. ROSSINI R, Angiolillo DJ, Musumeci G, Capodanno D, et al
    Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26629.
    PubMed     Text format     Abstract available


  270. MANOLY I, Hasan R, Brazier A, Farooq V, et al
    Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26610.
    PubMed     Text format     Abstract available


  271. COLLERAN R, Kufner S, Harada Y, Giacoppo D, et al
    Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26597.
    PubMed     Text format     Abstract available


  272. MASHAYEKHI K, Behnes M, Valuckiene Z, Bryniarski L, et al
    Comparison of the ipsi-lateral versus contra-lateral retrograde approach of percutaneous coronary interventions in chronic total occlusions.
    Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26611.
    PubMed     Text format     Abstract available


  273. SAFIAN RD
    Saphenous vein bypass graft intervention and embolic protection devices: Time for reassessment (and revision of percutaneous coronary intervention guidelines).
    Catheter Cardiovasc Interv. 2016;88:84-5.
    PubMed     Text format     Abstract available


  274. COLLET C, Serruys PW
    Coronary bifurcations in clinical practice: Tell me what we can do better.
    Catheter Cardiovasc Interv. 2016;88:71-2.
    PubMed     Text format     Abstract available


  275. BUTMAN SM
    In early returns scoring scores big.
    Catheter Cardiovasc Interv. 2016;88:60-1.
    PubMed     Text format     Abstract available


  276. DANEK BA, Brilakis ES
    How to prevent and treat complications of the retrograde approach to chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016;88:15-7.
    PubMed     Text format     Abstract available


    June 2016
  277. CHATTERJEE S, Yeh RW, Sardar P, Ul Hassan Virk H, et al
    Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data.
    Catheter Cardiovasc Interv. 2016 Jun 24. doi: 10.1002/ccd.26643.
    PubMed     Text format     Abstract available


  278. ARMSTRONG EJ, Graham L, Waldo SW, Valle JA, et al
    Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery.
    Catheter Cardiovasc Interv. 2016 Jun 17. doi: 10.1002/ccd.26624.
    PubMed     Text format     Abstract available


  279. ELLWEIN L, Marks DS, Migrino RQ, Foley WD, et al
    Image-based quantification of 3D morphology for bifurcations in the left coronary artery: Application to stent design.
    Catheter Cardiovasc Interv. 2016;87:1244-55.
    PubMed     Text format     Abstract available


  280. SHISHEHBOR MH, Aronow HD, Bartholomew JR, Beckman JA, et al
    Vascular specialist response to medicare evidence development coverage advisory committee (MEDCAC) panel on peripheral artery disease of the lower extremities.
    Catheter Cardiovasc Interv. 2016;87:1181-6.
    PubMed     Text format    


  281. SETO AH, Jordan Safirstein, Anwaruddin S, Dehghani P, et al
    Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
    Catheter Cardiovasc Interv. 2016;87:1224-30.
    PubMed     Text format     Abstract available


  282. QURESHI AM, Petit CJ, Crystal MA, Liou A, et al
    Efficacy and safety of catheter-based rheolytic and aspiration thrombectomy in children.
    Catheter Cardiovasc Interv. 2016;87:1273-80.
    PubMed     Text format     Abstract available


  283. HIRA RS, Dean LS
    Fork in the road: Are all bifurcations created equal?
    Catheter Cardiovasc Interv. 2016;87:1242-3.
    PubMed     Text format     Abstract available


  284. TOMMASO CL
    To aspirate or not!: The question may be not if, but when.
    Catheter Cardiovasc Interv. 2016;87:1211-2.
    PubMed     Text format     Abstract available


  285. SARDAR MR, Dawn Abbott J
    Myocardial salvage and mortality in STEMI: A race against ischemic time.
    Catheter Cardiovasc Interv. 2016;87:1201-2.
    PubMed     Text format     Abstract available


    May 2016
  286. FAZA NN, Mentias A, Parashar A, Chaudhury P, et al
    Bleeding Complications of Triple Antithrombotic Therapy after Percutaneous Coronary Interventions.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26574.
    PubMed     Text format     Abstract available


  287. JOSHI FR, Biasco L, Pedersen F, Holmvang L, et al
    Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26598.
    PubMed     Text format     Abstract available


  288. MURAI T, Kanaji Y, Yonetsu T, Lee T, et al
    Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26596.
    PubMed     Text format     Abstract available


  289. MAHMUD E, Dominguez A, Bahadorani J
    First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis.
    Catheter Cardiovasc Interv. 2016 May 18. doi: 10.1002/ccd.26550.
    PubMed     Text format     Abstract available


  290. BOCKSCH W, Grossmann B, Geisler T, Steeg M, et al
    Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26562.
    PubMed     Text format     Abstract available


  291. KARATASAKIS A, Tarar MN, Karmpaliotis D, Alaswad K, et al
    Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry.
    Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26568.
    PubMed     Text format     Abstract available


  292. CHANDRASEKHAR J, Baber U, Sartori S, Faggioni M, et al
    Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS Study.
    Catheter Cardiovasc Interv. 2016 May 6. doi: 10.1002/ccd.26606.
    PubMed     Text format     Abstract available


  293. GONSKA B, Seeger J, Rodewald C, Scharnbeck D, et al
    Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26565.
    PubMed     Text format     Abstract available


  294. IPEK G, Gungor B, Karatas MB, Onuk T, et al
    Risk factors and outcomes in patients with ectatic infarct-related artery who underwent primary percutaneous coronary intervention after ST elevated myocardial infarction.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26553.
    PubMed     Text format     Abstract available


  295. KAHLON TS, Barn K, Akram MM, Blankenship JC, et al
    Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26567.
    PubMed     Text format     Abstract available


    April 2016
  296. O'NEILL BP, Wheatley G, Bashir R, Edmundowicz D, et al
    Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial.
    Catheter Cardiovasc Interv. 2016 Apr 28. doi: 10.1002/ccd.26530.
    PubMed     Text format     Abstract available


  297. CARLINO M, Azzalini L, Colombo A
    A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Apr 28. doi: 10.1002/ccd.26556.
    PubMed     Text format     Abstract available


  298. ZAMAN S, Gooley R, Cheng V, McCormick L, et al
    Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Apr 23. doi: 10.1002/ccd.26371.
    PubMed     Text format     Abstract available


  299. TURNER ME, Addonizio LJ, Richmond ME, Zuckerman WA, et al
    Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Catheter Cardiovasc Interv. 2016 Apr 16. doi: 10.1002/ccd.26544.
    PubMed     Text format     Abstract available


  300. LATINI RA, Granata F, Ielasi A, Varricchio A, et al
    Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.
    Catheter Cardiovasc Interv. 2016 Apr 1. doi: 10.1002/ccd.26516.
    PubMed     Text format     Abstract available


    March 2016
  301. SOLHPOUR A, Chang KW, Arain SA, Balan P, et al
    Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myo
    Catheter Cardiovasc Interv. 2016 Mar 29. doi: 10.1002/ccd.26523.
    PubMed     Text format     Abstract available


  302. ADUSUMALLI S, Morris M, Pershad A
    Pseudo-Pericardial Tamponade From Right Ventricular Hematoma After Chronic Total Occlusion Percutaneous Coronary Intervention of the Right Coronary Artery: Successfully Managed Percutaneously With Computerized Tomographic Guided Drainage.
    Catheter Cardiovasc Interv. 2016 Mar 29. doi: 10.1002/ccd.26510.
    PubMed     Text format     Abstract available


  303. STETLER J, Karatasakis A, Christakopoulos GE, Tarar MN, et al
    Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Mar 25. doi: 10.1002/ccd.26505.
    PubMed     Text format     Abstract available


  304. IKEDA N, Kubota S, Okazaki T, Hara H, et al
    Comparison of intravascular optical frequency domain imaging versus intravascular ultrasound during balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    Catheter Cardiovasc Interv. 2016 Mar 18. doi: 10.1002/ccd.26437.
    PubMed     Text format     Abstract available


  305. PRASAD A, Ortiz-Lopez C, Khan A, Levin D, et al
    Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26466.
    PubMed     Text format     Abstract available


  306. MARKOVIC S, Lutzner M, Rottbauer W, Wohrle J, et al
    Zotarolimus compared with everolimus eluting stents-angiographic and clinical results after recanalization of true coronary chronic total occlusions.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26482.
    PubMed     Text format     Abstract available


  307. IQBAL MB, Nadra IJ, Ding L, Fung A, et al
    Long-term outcomes following drug-eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real-world analysis of 11,181 patients from the british columbia cardiac registry.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26479.
    PubMed     Text format     Abstract available


    February 2016
  308. PHILIP F, Stewart S, Southard JA
    Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
    Catheter Cardiovasc Interv. 2016 Feb 24. doi: 10.1002/ccd.26458.
    PubMed     Text format     Abstract available


  309. RITTGER H, Wohrle J, Brachmann J, Hohenforst-Schmidt W, et al
    Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Catheter Cardiovasc Interv. 2016 Feb 19. doi: 10.1002/ccd.26451.
    PubMed     Text format     Abstract available


  310. KHAN R, Al-Hawwas M, Hatem R, Azzalini L, et al
    Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Feb 1. doi: 10.1002/ccd.26413.
    PubMed     Text format     Abstract available


    November 2015
  311. LARMORE C, Effron MB, Molife C, DeKoven M, et al
    "Real-World" comparison of prasugrel with ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention in the United States.
    Catheter Cardiovasc Interv. 2015 Nov 18. doi: 10.1002/ccd.26279.
    PubMed     Text format     Abstract available


  312. ELGENDY IY, Wen X, Mahmoud A, Bavry AA, et al
    Complete versus culprit-only revascularization for patients with multi-vessel disease undergoing primary percutaneous coronary intervention: An updated meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26322.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: